{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:53:31Z","timestamp":1793832811118,"version":"4.6.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14899-y","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:45:31Z","timestamp":1759229131000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The integration of transcriptomics and metabolomics elucidates the antitumor mechanisms of mycophenolic acid in bladder cancer cells"],"prefix":"10.1186","volume":"25","author":[{"given":"Shanshan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunyang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"2","key":"14899_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","volume":"47","author":"AC Allison","year":"2000","unstructured":"Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology. 2000;47(2):85\u2013118.","journal-title":"Immunopharmacology"},{"issue":"9","key":"14899_CR2","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.3390\/cancers11091346","volume":"11","author":"R Naffouje","year":"2019","unstructured":"Naffouje R, Grover P, Yu H, Sendilnathan A, Wolfe K, Majd N et al. Anti-tumor potential of IMP dehydrogenase inhibitors: a century-long story. Cancers. 2019;11(9):1346. https:\/\/doi.org\/10.3390\/cancers11091346.","journal-title":"Cancers"},{"key":"14899_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173580","volume":"887","author":"J Benjanuwattra","year":"2020","unstructured":"Benjanuwattra J, Chaiyawat P, Pruksakorn D, Koonrungsesomboon N. Therapeutic potential and molecular mechanisms of mycophenolic acid as an anticancer agent. Eur J Pharmacol. 2020;887: 173580.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"14899_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t L, Hansel DE, Efstathiou JA, Knowles MA, Galsky MD, Teoh J et al. Bladder cancer. Nat Rev Dis Primers. 2023;9(1):58.","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"14899_CR5","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.urolonc.2021.01.013","volume":"40","author":"AS Feldman","year":"2022","unstructured":"Feldman AS, Kulkarni GS, Bivalacqua TJ, Black PC, Delacroix S, Lerner SP et al. Surgical challenges and considerations in tri-modal therapy for muscle invasive bladder cancer. Urol Oncol. 2022;40(10):442\u201350.","journal-title":"Urol Oncol"},{"issue":"7","key":"14899_CR6","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1097\/01.TP.0000154913.88193.FF","volume":"79","author":"M Elsharkawi","year":"2005","unstructured":"Elsharkawi M, Staib L, Henne-Bruns D, Mayer J. Complete remission of postransplant lung metastases from hepatocellular carcinoma under therapy with sirolimus and mycophenolate mofetil. Transplantation. 2005;79(7):855\u20137.","journal-title":"Transplantation"},{"issue":"4","key":"14899_CR7","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/ijc.2910570421","volume":"57","author":"RJ Tressler","year":"1994","unstructured":"Tressler RJ, Garvin LJ, Slate DL. Anti-tumor activity of mycophenolate mofetil against human and mouse tumors in vivo. Int J Cancer. 1994;57(4):568\u201373.","journal-title":"Int J Cancer"},{"issue":"12","key":"14899_CR8","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1002\/ijc.32735","volume":"146","author":"J Klangjorhor","year":"2020","unstructured":"Klangjorhor J, Chaiyawat P, Teeyakasem P, Sirikaew N, Phanphaisarn A, Settakorn J et al. Mycophenolic acid is a drug with the potential to be repurposed for suppressing tumor growth and metastasis in osteosarcoma treatment. Int J Cancer. 2020;146(12):3397\u2013409.","journal-title":"Int J Cancer"},{"issue":"11","key":"14899_CR9","doi-asserted-by":"publisher","first-page":"e81702","DOI":"10.1371\/journal.pone.0081702","volume":"8","author":"B Dun","year":"2013","unstructured":"Dun B, Sharma A, Teng Y, Liu H, Purohit S, Xu H et al. Mycophenolic acid inhibits migration and invasion of gastric cancer cells via multiple molecular pathways. PLoS One. 2013;8(11):e81702.","journal-title":"PLoS One"},{"key":"14899_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12885-016-2360-8","volume":"16","author":"N Heits","year":"2016","unstructured":"Heits N, Heinze T, Bernsmeier A, Kerber J, Hauser C, Becker T et al. Influence of mTOR-inhibitors and mycophenolic acid on human cholangiocellular carcinoma and cancer associated fibroblasts. BMC Cancer. 2016;16:322.","journal-title":"BMC Cancer"},{"issue":"6","key":"14899_CR11","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1158\/1535-7163.MCT-08-0193","volume":"7","author":"S Domhan","year":"2008","unstructured":"Domhan S, Muschal S, Schwager C, Morath C, Wirkner U, Ansorge W et al. Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid. Mol Cancer Ther. 2008;7(6):1656\u201368.","journal-title":"Mol Cancer Ther"},{"key":"14899_CR12","doi-asserted-by":"crossref","unstructured":"Drullion C, Lagarde V, Gioia R, Legembre P, Priault M, Cardinaud B et al. Mycophenolic Acid overcomes imatinib and nilotinib resistance of chronic myeloid leukemia cells by apoptosis or a senescent-like cell cycle arrest. Leukemia research and treatment. 2012; 2012:861301.","DOI":"10.1155\/2012\/861301"},{"issue":"12","key":"14899_CR13","first-page":"2880","volume":"6","author":"B Dun","year":"2013","unstructured":"Dun B, Xu H, Sharma A, Liu H, Yu H, Yi B et al. Delineation of biological and molecular mechanisms underlying the diverse anticancer activities of mycophenolic acid. Int J Clin Exp Pathol. 2013;6(12):2880\u20136.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"14899_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.canlet.2005.01.006","volume":"231","author":"D Floryk","year":"2006","unstructured":"Floryk D, Huberman E. Mycophenolic acid-induced replication arrest, differentiation markers and cell death of androgen-independent prostate cancer cells DU145. Cancer Lett. 2006;231(1):20\u20139.","journal-title":"Cancer Lett"},{"issue":"7","key":"14899_CR15","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.leukres.2006.12.019","volume":"31","author":"G V\u00e9gs\u0151","year":"2007","unstructured":"V\u00e9gs\u0151 G, Sebesty\u00e9n A, Paku S, Barna G, Hajdu M, T\u00f3th M et al. Antiproliferative and apoptotic effects of mycophenolic acid in human B-cell non-Hodgkin lymphomas. Leuk Res. 2007;31(7):1003\u20138.","journal-title":"Leuk Res"},{"issue":"1","key":"14899_CR16","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1038\/s41467-024-47965-3","volume":"15","author":"V Joo","year":"2024","unstructured":"Joo V, Abdelhamid K, Noto A, Latifyan S, Martina F, Daoudlarian D et al. Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene Laherparepvec therapy of squamous cell carcinoma. Nat Commun. 2024;15(1):3664.","journal-title":"Nat Commun"},{"issue":"2","key":"14899_CR17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1046\/j.1365-2249.2003.02290.x","volume":"134","author":"K Leckel","year":"2003","unstructured":"Leckel K, Beecken WD, Jonas D, Oppermann E, Coman MC, Beck KF et al. The immunosuppressive drug mycophenolate mofetil impairs the adhesion capacity of gastrointestinal tumour cells. Clin Exp Immunol. 2003;134(2):238\u201345.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"14899_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3892\/ijmm.2023.5282","volume":"52","author":"B Zhang","year":"2023","unstructured":"Zhang B, Yang L, He Y, Han D, Qi P, Shang P. Role and mechanisms of noncoding RNAs in the regulation of metabolic reprogramming in bladder cancer (Review). Int J Mol Med. 2023;52(3):79. https:\/\/doi.org\/10.3892\/ijmm.2023.5282","journal-title":"Int J Mol Med"},{"issue":"9","key":"14899_CR19","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1002\/cam4.1109","volume":"6","author":"D Sahu","year":"2017","unstructured":"Sahu D, Lotan Y, Wittmann B, Neri B, Hansel DE. Metabolomics analysis reveals distinct profiles of nonmuscle-invasive and muscle-invasive bladder cancer. Cancer Med. 2017;6(9):2106\u201320.","journal-title":"Cancer Med"},{"issue":"1","key":"14899_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41419-024-06446-7","volume":"15","author":"M Li","year":"2024","unstructured":"Li M, Yu J, Ju L, Wang Y, Jin W, Zhang R et al. USP43 stabilizes c-Myc to promote glycolysis and metastasis in bladder cancer. Cell Death Dis. 2024;15(1):44.","journal-title":"Cell Death Dis"},{"key":"14899_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ctrv.2016.03.005","volume":"45","author":"F Massari","year":"2016","unstructured":"Massari F, Ciccarese C, Santoni M, Iacovelli R, Mazzucchelli R, Piva F et al. Metabolic phenotype of bladder cancer. Cancer Treat Rev. 2016;45:46\u201357.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"14899_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13045-022-01312-5","volume":"15","author":"W Zhang","year":"2022","unstructured":"Zhang W, He X, Yin H, Cao W, Lin T, Chen W et al. Allosteric activation of the metabolic enzyme GPD1 inhibits bladder cancer growth via the lysoPC-PAFR-TRPV2 axis. J Hematol Oncol. 2022;15(1):93.","journal-title":"J Hematol Oncol"},{"issue":"45","key":"14899_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403995","volume":"11","author":"J Liu","year":"2024","unstructured":"Liu J, Luo Y, Chen S, Wang G, Jin W, Jiang W et al. Deubiquitylase USP52 promotes bladder cancer progression by modulating ferroptosis through stabilizing SLC7A11\/xCT. Adv Sci. 2024;11(45): e2403995.","journal-title":"Adv Sci"},{"issue":"5","key":"14899_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/iub.70028","volume":"77","author":"C Wang","year":"2025","unstructured":"Wang C, Shu Y, Shan J, Li K, Wan S, Chen S et al. Discovery and validation of a new biomarker integrating ferroptosis and glycolysis-related genes in bladder cancer. IUBMB Life. 2025;77(5): e70028.","journal-title":"IUBMB Life"},{"issue":"1","key":"14899_CR25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3390\/ijms24010449","volume":"24","author":"L Rochette","year":"2022","unstructured":"Rochette L, Dogon G, Rigal E, Zeller M, Cottin Y, Vergely C. Lipid peroxidation and iron metabolism: two corner stones in the homeostasis control of ferroptosis. Int J Mol Sci. 2022;24(1):449. https:\/\/doi.org\/10.3390\/ijms24010449","journal-title":"Int J Mol Sci"},{"issue":"8","key":"14899_CR26","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.7150\/ijbs.82875","volume":"19","author":"SS Liu","year":"2023","unstructured":"Liu SS, Li JS, Xue M, Wu WJ, Li X, Chen W. LncRNA UCA1 participates in de novo synthesis of guanine nucleotides in bladder cancer by recruiting TWIST1 to increase IMPDH1\/2. Int J Biol Sci. 2023;19(8):2599\u2013612.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"14899_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2174\/1574892811308020001","volume":"8","author":"R Petrelli","year":"2013","unstructured":"Petrelli R, Vita P, Torquati I, Felczak K, Wilson DJ, Franchetti P et al. Novel inhibitors of inosine monophosphate dehydrogenase in patent literature of the last decade. Recent Patents on Anti-Cancer Drug Discovery. 2013;8(2):103\u201325.","journal-title":"Recent Patents on Anti-Cancer Drug Discovery"},{"key":"14899_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.advenzreg.2006.01.002","volume":"46","author":"E Ol\u00e1h","year":"2006","unstructured":"Ol\u00e1h E, K\u00f6k\u00e9ny S, Papp J, Bozsik A, Keszei M. Modulation of cancer pathways by inhibitors of guanylate metabolism. Adv Enzyme Regul. 2006;46:176\u201390.","journal-title":"Adv Enzyme Regul"},{"issue":"1","key":"14899_CR29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.molcel.2012.04.030","volume":"47","author":"EN Kozhevnikova","year":"2012","unstructured":"Kozhevnikova EN, van der Knaap JA, Pindyurin AV, Ozgur Z, van Ijcken WF, Moshkin YM et al. Metabolic enzyme IMPDH is also a transcription factor regulated by cellular state. Mol Cell. 2012;47(1):133\u20139.","journal-title":"Mol Cell"},{"issue":"1","key":"14899_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0090-4295(75)90322-2","volume":"5","author":"JG Connolly","year":"1975","unstructured":"Connolly JG, Halsall GM. Use of mycophenolic acid in superifical bladder cancer. Urology. 1975;5(1):131\u20132.","journal-title":"Urology"},{"key":"14899_CR31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.21037\/tgh.2017.09.06","volume":"2","author":"J Lerut","year":"2017","unstructured":"Lerut J, Iesari S, Foguenne M, Lai Q. Hepatocellular cancer and recurrence after liver transplantation: what about the impact of immunosuppression? Transl Gastroenterol Hepatol. 2017;2:80.","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"9","key":"14899_CR32","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1093\/clinchem\/46.9.1376","volume":"46","author":"O Millan","year":"2000","unstructured":"Millan O, Oppenheimer F, Brunet M, Vilardell J, Rojo I, Vives J et al. Assessment of mycophenolic acid-induced immunosuppression: a new approach. Clin Chem. 2000;46(9):1376\u201383.","journal-title":"Clin Chem"},{"issue":"Suppl 1","key":"14899_CR33","doi-asserted-by":"publisher","first-page":"s2","DOI":"10.1177\/096120330501400102","volume":"14","author":"AC Allison","year":"2005","unstructured":"Allison AC. Mechanisms of action of mycophenolate mofetil. Lupus. 2005;14(Suppl 1):s2-8.","journal-title":"Lupus"},{"issue":"Suppl 17","key":"14899_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1399-0012.2006.00597.x","volume":"20","author":"C Morath","year":"2006","unstructured":"Morath C, Schwenger V, Beimler J, Mehrabi A, Schmidt J, Zeier M et al. Antifibrotic actions of mycophenolic acid. Clin Transplant. 2006;20(Suppl 17):25\u20139.","journal-title":"Clin Transplant"},{"key":"14899_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"M Dodson","year":"2019","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019;23: 101107.","journal-title":"Redox Biol"},{"issue":"12","key":"14899_CR36","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.tcb.2023.05.003","volume":"33","author":"LE Pope","year":"2023","unstructured":"Pope LE, Dixon SJ. Regulation of ferroptosis by lipid metabolism. Trends Cell Biol. 2023;33(12):1077\u201387.","journal-title":"Trends Cell Biol"},{"issue":"4","key":"14899_CR37","doi-asserted-by":"publisher","first-page":"603","DOI":"10.18632\/aging.100934","volume":"8","author":"G Pistritto","year":"2016","unstructured":"Pistritto G, Trisciuoglio D, Ceci C, Garufi A, D\u2019Orazi G. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging. 2016;8(4):603\u201319.","journal-title":"Aging"},{"key":"14899_CR38","doi-asserted-by":"publisher","first-page":"1428920","DOI":"10.3389\/fimmu.2024.1428920","volume":"15","author":"Y Cao","year":"2024","unstructured":"Cao Y, Lu C, Beeraka NM, Efetov S, Enikeev M, Fu Y et al. Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation. Front Immunol. 2024;15:1428920.","journal-title":"Front Immunol"},{"issue":"2","key":"14899_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.747","volume":"12","author":"X Xue","year":"2022","unstructured":"Xue X, Ma L, Zhang X, Xu X, Guo S, Wang Y et al. Tumour cells are sensitised to ferroptosis via RB1CC1-mediated transcriptional reprogramming. Clin Transl Med. 2022;12(2): e747.","journal-title":"Clin Transl Med"},{"key":"14899_CR40","doi-asserted-by":"crossref","unstructured":"Feng X, Yi X, Huo B, Luo H, Chen J, Guo X, Fang ZM, Gong FH, Wei X, Jiang DS, Chen Y. Lactate dehydrogenase A is a novel positive regulator of vascular smooth muscle cell ferroptosis during aortic dissection. Antioxidants & redox signaling; 2024.","DOI":"10.1089\/ars.2024.0585"},{"issue":"5","key":"14899_CR41","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.7150\/ijbs.83342","volume":"19","author":"Y Feng","year":"2023","unstructured":"Feng Y, Dai Y. Apol3-LDHA axis related immunity activation and cancer ferroptosis induction. Int J Biol Sci. 2023;19(5):1401\u20132.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"14899_CR42","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.7150\/ijbs.74985","volume":"19","author":"Y Lv","year":"2023","unstructured":"Lv Y, Tang W, Xu Y, Chang W, Zhang Z, Lin Q et al. Apolipoprotein L3 enhances CD8\u2009+\u2009T cell antitumor immunity of colorectal cancer by promoting LDHA-mediated ferroptosis. Int J Biol Sci. 2023;19(4):1284\u201398.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"14899_CR43","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41418-024-01427-x","volume":"32","author":"L Zhao","year":"2024","unstructured":"Zhao L, Deng H, Zhang J, Zamboni N, Yang H, Gao Y et al. Lactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancer. Cell Death Differ. 2025;32(4):632\u201345. https:\/\/doi.org\/10.1038\/s41418-024-01427-x.","journal-title":"Cell Death Differ"},{"key":"14899_CR44","doi-asserted-by":"publisher","unstructured":"Peng X, Sun B, Tang C, Shi C, Xie X, Wang X et al. HMOX1-LDHB interaction promotes ferroptosis by inducing mitochondrial dysfunction in foamy macrophages during advanced atherosclerosis. Dev Cell. 2025;60(7):1070-1086.e8. https:\/\/doi.org\/10.1016\/j.devcel.2024.12.011.","DOI":"10.1016\/j.devcel.2024.12.011"},{"issue":"6","key":"14899_CR45","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00204-023-03476-6","volume":"97","author":"B Wang","year":"2023","unstructured":"Wang B, Wang Y, Zhang J, Hu C, Jiang J, Li Y et al. ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis. Arch Toxicol. 2023;97(6):1439\u201351.","journal-title":"Arch Toxicol"},{"key":"14899_CR46","doi-asserted-by":"crossref","unstructured":"Su LJ, Zhang JH, Gomez H, Murugan R, Hong X, Xu D et al. Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis. Oxidative medicine and cellular longevity. 2019; 2019:5080843.","DOI":"10.1155\/2019\/5080843"},{"issue":"4","key":"14899_CR47","first-page":"623","volume":"44","author":"Q Zhao","year":"2015","unstructured":"Zhao Q, Li Z, Ding Y, Shi Y, Le G. Effects of tyrosine oxidation products on redox state in myocardium of rats. Wei Sheng Yan jiu = J Hygiene Res. 2015;44(4):623\u20137.","journal-title":"Wei Sheng Yan jiu = J Hygiene Res"},{"issue":"1","key":"14899_CR48","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11011-019-00511-3","volume":"35","author":"M Carvalho-Silva","year":"2020","unstructured":"Carvalho-Silva M, Gomes LM, de Pr\u00e1 SD, Wessler LB, Schuck PF, Scaini G et al. Evidence of hippocampal astrogliosis and antioxidant imbalance after L-tyrosine chronic administration in rats. Metab Brain Dis. 2020;35(1):193\u2013200.","journal-title":"Metab Brain Dis"},{"issue":"1","key":"14899_CR49","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1038\/s41467-020-17242-0","volume":"11","author":"M Arra","year":"2020","unstructured":"Arra M, Swarnkar G, Ke K, Otero JE, Ying J, Duan X et al. LDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis. Nat Commun. 2020;11(1):3427.","journal-title":"Nat Commun"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14899-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14899-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14899-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:30:19Z","timestamp":1759275019000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14899-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14899"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14899-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1463"}}